Abcellera Biologics Inc
NASDAQ:ABCL

Watchlist Manager
Abcellera Biologics Inc Logo
Abcellera Biologics Inc
NASDAQ:ABCL
Watchlist
Price: 2.665 USD -2.02%
Market Cap: 785.3m USD
Have any thoughts about
Abcellera Biologics Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
Abcellera Biologics Inc

Current Assets 742.9m
Cash & Short-Term Investments 643.1m
Receivables 63.2m
Other Current Assets 36.5m
Non-Current Assets 649.9m
Long-Term Investments 84.1m
PP&E 331.3m
Intangibles 100.4m
Other Non-Current Assets 134.2m
Current Liabilities 79.6m
Accounts Payable 34.8m
Accrued Liabilities 11.1m
Other Current Liabilities 33.7m
Non-Current Liabilities 235.2m
Other Non-Current Liabilities 235.2m

Balance Sheet
Abcellera Biologics Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
10
8
594
476
387
133
Cash Equivalents
10
8
594
476
387
133
Short-Term Investments
1
2
1
247
500
627
Total Receivables
4
2
212
175
103
64
Accounts Receivables
1
1
212
161
39
31
Other Receivables
3
1
0
14
65
34
Inventory
0
0
0
2
2
1
Other Current Assets
1
1
6
30
34
46
Total Current Assets
15
13
813
930
1 026
872
PP&E Net
6
9
18
112
217
288
PP&E Gross
6
9
18
112
217
288
Accumulated Depreciation
2
3
6
10
19
31
Intangible Assets
0
0
115
148
132
120
Goodwill
0
0
32
48
48
48
Note Receivable
0
2
0
0
0
0
Long-Term Investments
0
0
19
50
73
98
Other Long-Term Assets
0
1
8
31
46
62
Other Assets
0
0
32
48
48
48
Total Assets
22
N/A
24
+9%
1 006
+4 179%
1 319
+31%
1 541
+17%
1 488
-3%
Liabilities
Accounts Payable
2
2
7
15
15
26
Accrued Liabilities
0
0
1
4
12
14
Short-Term Debt
0
0
0
0
0
0
Current Portion of Long-Term Debt
3
2
0
0
0
0
Other Current Liabilities
2
3
96
102
92
80
Total Current Liabilities
6
8
104
121
118
119
Long-Term Debt
1
1
2
0
0
0
Deferred Income Tax
0
0
26
37
33
31
Other Liabilities
3
4
43
135
156
186
Total Liabilities
10
N/A
13
+33%
175
+1 226%
293
+67%
308
+5%
336
+9%
Equity
Common Stock
13
13
710
722
734
753
Retained Earnings
3
5
114
268
426
280
Additional Paid In Capital
2
2
6
35
74
121
Other Equity
0
0
0
0
1
2
Total Equity
12
N/A
10
-11%
831
+7 963%
1 026
+24%
1 233
+20%
1 152
-7%
Total Liabilities & Equity
22
N/A
24
+9%
1 006
+4 179%
1 319
+31%
1 541
+17%
1 488
-3%
Shares Outstanding
Common Shares Outstanding
266
266
270
283
287
291

See Also

Discover More